Effects of a Reduction in Kidney Function on Cardiovascular Structure and Function: A Prospective Study of Kidney Donors
Does a Reduction in Renal Function Increase Arterial Stiffness and Left Ventricular Mass? - A Prospective Study of Kidney Donors
1 other identifier
observational
124
1 country
1
Brief Summary
Studies of patients with established kidney disease, even when this is mild, appear to show that they are at high risk of heart failure, stroke and sudden cardiac death. This may be because kidney disease causes stiffening of the arteries in the body which means that the heart and brain are damaged by high blood pressure. By studying patients before and after the removal of a kidney (uni-nephrectomy) for transplantation the investigators will find out for the first time in man the effect of an isolated reduction in kidney function on the structure and function of the arteries and heart. Hypotheses. An isolated reduction in GFR occuring after surgical uni-nephrectomy is associated with long term adverse cardiac and vascular effects which include:
- 1.Increased arterial stiffness and left ventricular mass
- 2.Abnormalities in left ventricular systolic and diastolic function
- 3.Increased oxidative stress, inflammation and collagen turnover
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2009
CompletedFirst Posted
Study publicly available on registry
December 9, 2009
CompletedStudy Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedDecember 3, 2015
December 1, 2015
3.9 years
December 8, 2009
December 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Left ventricular mass as measured by CMR and Echocardiography
3 years
Arterial stiffness as measured by pulse wave velocity
3 years
Secondary Outcomes (3)
Aortic compliance measured by cardiac magnetic resonance imaging
3 years
Left ventricular systolic and diastolic elastance measured by echocardiography;
3 years
Oxidative stress, inflammation and collagen turnover measured by blood assays of plasma renin, aldosterone, high sensitivity C-reactive protein (hsCRP), procollagen type III aminoterminal peptide (PIIINP) and C-telopeptide for type I collagen (CITP).
3 years
Study Arms (2)
Donors
110 will be "cases" that undergo uninephrectomy
Controls
110 "controls"
Eligibility Criteria
Renal outpatient clinic
You may qualify if:
- Potential kidney donor attending University Hospital Birmingham NHS Foundation Trust
You may not qualify if:
- Diabetes mellitus
- Atrial fibrillation
- Left ventricular dysfunction (ejection fraction \<40% on transthoracic echocardiography)
- History of cardiovascular or pulmonary disease
- Evidence of hypertensive end-organ damage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Birmingham NHS Foundation Trust
Birmingham, West Midlands, B15 2TT, United Kingdom
Related Publications (1)
Moody WE, Ferro CJ, Edwards NC, Chue CD, Lin EL, Taylor RJ, Cockwell P, Steeds RP, Townend JN; CRIB-Donor Study Investigators. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors. Hypertension. 2016 Feb;67(2):368-77. doi: 10.1161/HYPERTENSIONAHA.115.06608.
PMID: 26754643DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan N Townend
Univeristy Hospital Birmingham NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- BHF Clinical Research Fellow
Study Record Dates
First Submitted
December 8, 2009
First Posted
December 9, 2009
Study Start
September 1, 2010
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
December 3, 2015
Record last verified: 2015-12